0      0

2022 AABB Annual Meeting

AM22-ST19-E - AM22-ST19-E: (On-Demand) Low-Yield Platelets: An Effective Solution to Our Platelet Shortage? (Enduring)

Oct 4, 2022 12:00pm ‐ Oct 4, 2022 1:00pm

Credits: None available.


A national shortage of blood components, especially platelets, have resulted in the need for creative ways of meeting the platelet needs of patients. Low-yield platelets are apheresis-derived platelets that contain less than 3.0 x 1011 platelets, which is the minimum required for a “standard-dose” platelet according to Food and Drug Administration regulations. Low-yield platelets may range from 2.6 to 2.9 x 1011 platelets which is approximately 10-15% fewer than a standard apheresis unit. The goal of this education session is to discuss the overall impact of low-yield platelets on blood centers, donors and recipients.

Learning Objectives:
  • Summarize current Food and Drug Administration regulations on platelet products.
  • Discuss current evidence for the safety and efficacy of low yield platelets in transfused patients.
  • Discuss the impact of low yield platelets on overall platelet supply.
  • Describe criteria for receiving low-yield platelet products and for billing.


  • Wen Lu, MD, Brigham and Women's Hospital
  • Tanya Petraszko, Canadian Blood Services, University of British Columbia



  • Wen Lu, MD : Nothing to Disclose
  • Yvette Tanhehco, PhD MD MS : Nothing to Disclose
  • Tanya Petraszko : Nothing to Disclose


Credits: None available.

You must be logged in and own this session in order to post comments.